Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Libman

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Prehospital and Disaster Medicine|December 8, 1996
The need for a global health disaster networkI M Libman, R E LaPorte, S Akazawa, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 22, 2017
Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical TrialPetter Bjornstad, Edward Nehus, Laure El Ghormli, et al.
Bulletin of Experimental Biology and Medicine|August 12, 2003
Qualitative assessment of selective blockade of M(4)-cholinoreceptors in the whole organismS G Dagaev, A B Kosmachev, N M Libman, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|February 24, 2001
[Characteristics of effects of acetylene amino alcohols M-cholinoreceptor blockers on the dopaminergic system in Daphnia magna]A B Kosmachev, V D Tonkopiĭ, N P Podosinovikova, et al.
Pediatric Diabetes|January 5, 2006
Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodiesMassimo Pietropaolo, Shui Yu, Ingrid M Libman, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2017
The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk AdultsChristine T Ferrara, Susan M Geyer, Carmella Evans-Molina, et al.
Diabetes Care|September 9, 2020
The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention StudyHeba M Ismail, Mario A Cleves, Ping Xu, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
Travel-acquired infections in Canada: CanTravNet 2011-2012A K Boggild, J Geduld, M Libman, et al.
Diabetes Care|January 24, 2013
Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelinesJamie R Wood, Kellee M Miller, David M Maahs, et al.
Pediatric Diabetes|November 25, 2017
The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1Jay M Sosenko, Susan Geyer, Jay S Skyler, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Prehospital and Disaster Medicine|December 8, 1996
The need for a global health disaster networkI M Libman, R E LaPorte, S Akazawa, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 22, 2017
Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical TrialPetter Bjornstad, Edward Nehus, Laure El Ghormli, et al.
Bulletin of Experimental Biology and Medicine|August 12, 2003
Qualitative assessment of selective blockade of M(4)-cholinoreceptors in the whole organismS G Dagaev, A B Kosmachev, N M Libman, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|February 24, 2001
[Characteristics of effects of acetylene amino alcohols M-cholinoreceptor blockers on the dopaminergic system in Daphnia magna]A B Kosmachev, V D Tonkopiĭ, N P Podosinovikova, et al.
Pediatric Diabetes|January 5, 2006
Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodiesMassimo Pietropaolo, Shui Yu, Ingrid M Libman, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2017
The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk AdultsChristine T Ferrara, Susan M Geyer, Carmella Evans-Molina, et al.
Diabetes Care|September 9, 2020
The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention StudyHeba M Ismail, Mario A Cleves, Ping Xu, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
Travel-acquired infections in Canada: CanTravNet 2011-2012A K Boggild, J Geduld, M Libman, et al.
Diabetes Care|January 24, 2013
Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelinesJamie R Wood, Kellee M Miller, David M Maahs, et al.
Pediatric Diabetes|November 25, 2017
The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1Jay M Sosenko, Susan Geyer, Jay S Skyler, et al.
Pageof 9